Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 14441
Country/Region: Malawi
Year: 2017
Main Partner: Lighthouse Trust
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $5,014,295 Additional Pipeline Funding: $600,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $601,715
Care: Pediatric Care and Support (PDCS) $100,285
Health Systems Strengthening (OHSS) $0
Testing: HIV Testing and Counseling (HVCT) $250,715
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $3,560,150
Treatment: Pediatric Treatment (PDTX) $501,430
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 72,475
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 42
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 2,808
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 4,225
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 5,469
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 28
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 385
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 3,079
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 671
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 650
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 1,190
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 1,069
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 1,190
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 1,069
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 4,958
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 7,452
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 50
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 122
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 977
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 213
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 207
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 80
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 91
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 80
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 91
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 256
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 336
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 2
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 17
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 151
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 33
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 31
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 158
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 654
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 158
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 654
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 448
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 1,091
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 4
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 57
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 14
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 109
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 24
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 24
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 178
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 434
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 178
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 434
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 914
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 2,022
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 9
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 106
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 15
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 120
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 26
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 25
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 1,462
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 1,796
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 1,462
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 1,796
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 3,891
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 6,320
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 39
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 333
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 364
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 364
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 3,796
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 200
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 18
HTS_TST Sum of Test Result disaggregates 2018 5,801
HTS_TST_POS By Test Result: Positive 2018 5,801
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 80
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 225
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 498
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 39
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 306
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 66
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 118
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 106
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 118
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 106
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 494
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 700
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 97
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 26
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 44
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 109
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) TB: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 43
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 43
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 91
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 201
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 145
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 179
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 145
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 179
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 387
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 628
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 70
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 4
PMTCT_ART Already on ART at beginning of current pregnancy 2018 420
PMTCT_ART New on ART 2018 529
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 949
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 14,098
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 949
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 486
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 421
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 16
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 26
PMTCT_STAT By Age (Numerator): 10-14 2018 42
PMTCT_STAT By Age (Numerator): 15-19 2018 2,960
PMTCT_STAT By Age (Numerator): 20-24 2018 4,652
PMTCT_STAT By Age (Numerator): 25-49 2018 6,416
PMTCT_STAT By Age (Numerator): 50+ 2018 28
PMTCT_STAT By Number of known positives: 15-19 2018 73
PMTCT_STAT By Number of known positives: 20-24 2018 203
PMTCT_STAT By Number of known positives: 25-49 2018 447
PMTCT_STAT By Number of new negative: 10-14 2018 42
PMTCT_STAT By Number of new negative: 15-19 2018 2,808
PMTCT_STAT By Number of new negative: 20-24 2018 4,225
PMTCT_STAT By Number of new negative: 25-49 2018 5,468
PMTCT_STAT By Number of new negative: 50+ 2018 28
PMTCT_STAT By Number of new positives: 15-19 2018 80
PMTCT_STAT By Number of new positives: 20-24 2018 225
PMTCT_STAT By Number of new positives: 25-49 2018 499
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 14,098
PMTCT_STAT_den By Age (Denominator): <15-19 2018 3,116
PMTCT_STAT_den By Age (Denominator): 10-14 2018 45
PMTCT_STAT_den By Age (Denominator): 20-24 2018 4,898
PMTCT_STAT_den By Age (Denominator): 25-49 2018 6,752
PMTCT_STAT_den By Age (Denominator): 50+ 2018 29
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 50
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 50
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 616
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 292
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,066
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,008
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 54
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 54
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 649
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 309
TB_PREV By Age/Sex (Numerator): <15, Female 2018 1,499
TB_PREV By Age/Sex (Numerator): <15, Male 2018 1,419
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 18,939
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 10,519
TB_PREV By Therapy type (Numerator): Continuous IPT 2018 32,376
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 32,376
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 33,369
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 1,545
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 1,462
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 19,520
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 10,842
TB_PREV_den By Therapy type (Denominator): Continuous IPT 2018 33,369
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 92
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 526
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 92
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,112
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,822
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,851
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 92
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 538
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 92
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,129
TX_CURR Age/Sex: <1 2018 516
TX_CURR Age/Sex: <1-9 2018 2,689
TX_CURR Age/Sex: 10-14 Female 2018 391
TX_CURR Age/Sex: 10-14 Male 2018 378
TX_CURR Age/Sex: 15-19 Female 2018 882
TX_CURR Age/Sex: 15-19 Male 2018 371
TX_CURR Age/Sex: 20-24 Female 2018 1,251
TX_CURR Age/Sex: 20-24 Male 2018 371
TX_CURR Age/Sex: 25-49 Female 2018 18,682
TX_CURR Age/Sex: 25-49 Male 2018 11,097
TX_CURR Age/Sex: 50+ Female 2018 131
TX_CURR Age/Sex: 50+ Male 2018 584
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 37,343
TX_CURR Sum of age/sex disaggregates 2018 1,253
TX_NEW Breastfeeding status 2018 346
TX_NEW By Age/Sex: <1 2018 40
TX_NEW By Age/Sex: 1-9 2018 456
TX_NEW By Age/Sex: 10-14 Female 2018 63
TX_NEW By Age/Sex: 10-14 Male 2018 57
TX_NEW By Age/Sex: 15-19 Female 2018 490
TX_NEW By Age/Sex: 15-19 Male 2018 560
TX_NEW By Age/Sex: 20-24 Female 2018 688
TX_NEW By Age/Sex: 20-24 Male 2018 560
TX_NEW By Age/Sex: 25-49 Female 2018 1,383
TX_NEW By Age/Sex: 25-49 Male 2018 1,616
TX_NEW By Age/Sex: 50+ Female 2018 10
TX_NEW By Age/Sex: 50+ Male 2018 85
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 6,008
TX_NEW Pregnancy status 2018 1,276
TX_NEW Sum of Age/Sex disaggregates 2018 5,512
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 25,819
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 23,238
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 676
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 20
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 676
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 20
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 13,762
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 414
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 7,448
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 222
TX_PVLS Numerator: Indication: Routine 2018 22,562
TX_PVLS Numerator: Indication: Targeted 2018 676
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 2,864
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 86
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 2,864
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 86
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 752
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 22
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 752
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 22
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 15,291
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 457
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 8,272
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 251
TX_PVLS_den Denominator: Indication: Routine 2018 25,067
TX_PVLS_den Denominator: Indication: Targeted 2018 752
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 3,183
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 96
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 3,183
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 96
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 187
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 187
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 3,266
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,659
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 5,299
TX_RET Numerator by Status: Breastfeeding 2018 166
TX_RET Numerator by Status: Pregnant 2018 90
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 7,433
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 297
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 297
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 4,535
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,304
TX_RET_den Denominator by Status: Breastfeeding 2018 208
TX_RET_den Denominator by Status: Pregnant 2018 111
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 32,703
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 334
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 18
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 18
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 190
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 108
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,636
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 1,636
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 18,967
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 10,464
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 254
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 12
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 1,007
TX_TB_den Denominator: By Screen Result: Negative 2018 30,766
TX_TB_den Denominator: By Screen Result: Positive 2018 1,250
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 1,250
Cross Cutting Budget Categories and Known Amounts Total: $957,100
Key Populations: Sex Workers $2,300
Training of health workers and community outreach workers
Key Populations: MSM and TG $2,300
Human Resources for Health $867,500
Food and Nutrition: Commodities $10,000
Motor Vehicles: Purchased $55,000
Renovation $20,000